Diabetes Mellitus in Pregnancy
13
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Patient Empowerment in the Management of Gestational Diabetes Mellitus
SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Extended Criteria For Fetal Myelomeningocele Repair
Postpartum Weight Loss for Women at Elevated Cardiovascular Risk
Glycemic Targets for Pregnant Women With GDM and T2DM
Biomarkers During Pregnancy
Comparative Effects of Metformin and Insulin on Stereological Studies and Immunohistochemistry of Placenta
Efficacy of FGM in Pregestational Diabetes
Berlin-Brandenburg Pregnancy Cohort
Diabetes in Pregnancy and Pregnancy Outcomes
Gestational Diabetes: a Cohort Study
Insulin Resistance and Hypertensive Disorders in Pregnancy